Results 31 to 40 of about 1,181 (123)
BMC Ophthalmology, 2021 Background The use of Spectral domain optical coherence tomography (SD-OCT) to evaluate the predictors of visual acuity-recovery in patients treated with conbercept for macular edema (ME) secondary to central retinal vein occlusion (CRVO) has rarely been
Qi Zhang +8 more
doaj +1 more source
Short-term effects of intravitreal Conbercept injection combined with laser photocoagulation on macular edema secondary to ischemic retinal vein occlusion [PDF]
International Journal of Ophthalmology, 2021 AIM: To observe changes in the best-corrected visual acuity (BCVA), central macular thickness (CMT), and central choroidal thickness (CCT) of patients with macular edema (ME) secondary to ischemic retinal vein occlusion (iRVO) following intravitreal ...
Zheng-Feng Liu +6 more
doaj +1 more source
The Role of Intravitreal Anti-VEGF Agents in Rabbit Eye Model of Open-Globe Injury
Journal of Ophthalmology, 2021 Purpose. To evaluate the effects of intravitreal anti-VEGF agents in a rabbit model of open-globe injury (OGI). Methods. OGI was induced in the right eyes of 75 Belgian rabbits by making 5 mm circumferential incision placed 6 mm behind the limbus.
Xiao Zhao +10 more
doaj +1 more source
Acta Ophthalmologica, Volume 104, Issue 7, Page e724-e744, November 2026.Abstract Coats disease diagnosed in adulthood is a rare idiopathic retinal telangiectatic vasculopathy that may differ in phenotype from childhood‐diagnosed cases. This systematic review synthesizes current evidence to characterize its clinical spectrum, imaging features, treatment outcomes and underlying mechanisms, with a focus on immunovascular ...
Catarina Francisco +2 more
wiley +1 more source
Dissecting the angiogenic mechanism of pachychoroid polypoidal choroidal vasculopathy
iMeta, Volume 5, Issue 5, October 2026.A prognosis‐oriented classification system was established to distinguish Pachy PCV from Non‐pachy PCV using a large multicenter dataset. Comparative plasma multi‐omics profiling of Pachy PCV, Non‐pachy PCV, and normal controls revealed unique upregulation of the fluid shear stress and atherosclerosis (FSS‐AS) and HIF‐1 signaling pathways in Pachy PCV.
Xinyu Zhao +18 more
wiley +1 more source
BMC Ophthalmology, 2017 Background To compare the efficacy of intravitreal conbercept and ranibizumab in the treatment of diabetic macular edema (DME) in a real-life clinical practice. Methods This was a retrospective study.
Yule Xu +4 more
doaj +1 more source
Intravitreal conbercept injection for neovascular age-related macular degeneration [PDF]
International Journal of Ophthalmology, 2019 AIM: To evaluate the efficacy and safety of intravitreal injection of conbercept in patients with neovascular age-related macular degeneration (AMD). METHODS: Retrospective review of 66 eyes of 63 patients with neovascular AMD. All patients received 0.5
Bing-Hui Wu +4 more
doaj +1 more source
Advanced Science, Volume 13, Issue 16, 18 March 2026.An integrated approach that combines a DNA nanoflower VEGF degrader with photodynamic therapy is developed for the treatment of wet age‐related macular degeneration, which reduces the risk of VEGF reactivation‐induced CNV recurrence and minimizes the systemic side effects associated with photodynamic therapy.
Mengxuan Li +11 more
wiley +1 more source
BMC Ophthalmology, 2018 Background Macular neovascular diseases can cause severe vision loss. A newly approved anti—VEGF drug Conbercept has shown good efficacy and safety in rigorous random controlled trials (RCT), however, it cannot fully reflect the clinical application of ...
Jin Jing +7 more
doaj +1 more source
The Efficacy of Conbercept in Polypoidal Choroidal Vasculopathy: A Systematic Review
Journal of Ophthalmology, 2020 Topic. The aim of this study is to evaluate the efficacy of conbercept in PCV, which will optimize the management for PCV patients. Clinical Relevance. The use of antivascular endothelial growth factor (VEGF) therapy in polypoidal choroidal vasculopathy (
Yimin Wang +4 more
doaj +1 more source